Skip to content

Neuroplasticity: all studies

Page 114 of 178: studies 1,131 to 1,140 of 1,772, newest first. Back to the neuroplasticity overview

Research

Low-dose intravenous esketamine on a depressive catatonia patient with venous thromboembolism: a case report.

Frontiers in Psychiatry 2025 Meng-Han Zhang, Yi-Fan Wang, Juan Li et al.

Catatonia is a rare but potentially life-threatening psycho-motor syndrome. It is mainly manifested as decreased activities, or excessive and specific activities, such as stupor, agitation and defiance. Catatonia can appear in various diseases and the diagnosis and treatment of depressive catatonia are often delayed. As an N-methyl-D-aspartate (NMDA) receptor antagonist, esketamine shows...

DOI: 10.3389/fpsyt.2025.1688633 (opens in new tab) Full text (opens in new tab) Major depressive disorder N-methyl-d-aspartate receptor antagonist Venousthromboembolism Catatonia treatment +1

From contemplation to serenity: how yoga meditation improves the mental health of female college students?

Frontiers in Psychology 2025 Lanjuan Liu, Cheng Liu, Lijun Tang et al. 4 citations

This study aims to investigate the impact of yoga meditation on the mental health of female college students, focusing on how meditation improves emotional regulation, alleviates stress and strengthens psychological resilience. Employing a combination of quantitative assessment and qualitative analysis, the study measured participants' emotional states, stress levels, and psychological...

DOI: 10.3389/fpsyg.2025.1545943 (opens in new tab) Full text (opens in new tab) Emotional regulation Mental health Psychological resilience Stress relief +1

Mindfulness and MBCT-vision (mindfulness-based cognitive therapy modified for visual symptoms) for visual snow syndrome: a therapeutic perspective.

Frontiers in Neurology 2025 Sui H Wong, Janet Wingrove 1 citation

Visual snow syndrome (VSS) is a neurological disorder characterized by intrusive visual symptoms and associated with dysregulation in brain networks, including the Salience Network, Default Mode Network, and thalamocortical circuits. This perspective paper examines the application of mindfulness-based cognitive therapy modified for visual symptoms (MBCT-vision) as an intervention for VSS....

DOI: 10.3389/fneur.2025.1596642 (opens in new tab) Full text (opens in new tab) Default mode network Attention network Lifestyle intervention Mindfulness-based intervention +2

Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.

Frontiers in Immunology 2025 David Qixiang Chen, José Adalberto Inzunza Domínguez, Juan Manuel Valle Uzeta et al. 3 citations

Multiple sclerosis (MS) is a debilitating neurodegenerative disease characterized by demyelination and neuronal loss. Traditional therapies often fail to halt disease progression or reverse neurological deficits. Ibogaine, a psychoactive alkaloid, has been proposed as a potential neuroregenerative agent due to its multifaceted pharmacological profile. We present two case studies of MS patients...

[Mechanisms of action and therapeutic perspectives of LSD: Current status].

Biologie aujourd'hui 2025 Amel Bouloufa, Sarah Delcourte, Nasser Haddjeri

Major depressive disorder (MDD) is a prevalent and disabling condition affecting over 350 million individuals worldwide. Although conventional antidepressants targeting serotonin, dopamine, and noradrenaline pathways provide benefit for many, a substantial proportion of patients experience inadequate response. Treatment-resistant depression (TRD), defined by failure to respond to at least two...

Correlation analysis between clinical effective emotional treatment and plasma N-methyl-D-aspartate receptor function-related indexes.

Frontiers in Neuroscience 2025 Zuxing Feng, Yanli Li, Ying Cai et al. 2 citations Retracted

With the use of ketamine, Glutamate (Glu) system has gradually become the focus of antidepressant effects. N-methyl-D-aspartate receptor (NMDAR), as one of the major ionic glutamate receptors, plays a dominant role in antidepressant effects, especially in synaptic plasticity. Few studies have been conducted on changes of NMDAR-related indicators and inflammatory cytokines in major depressive...

DOI: 10.3389/fnins.2025.1608722 (opens in new tab) Full text (opens in new tab) N-methyl-d-aspartate receptor nmdar Metabolism Antidepressant therapy Depression recovery +12

Serotonergic psychedelic 5-MeO-DMT alters plasticity-related gene expression and generates anxiolytic effects in stressed mice.

Molecular Psychiatry 2025 Margareth Nogueira, Daiane C Ferreira Golbert, Richardson Menezes et al. 18 citations

Serotonergic psychedelics have potential therapeutic effects in treating anxiety and mood disorders, often after a single dose, and are suggested to have plasticity-inducing action. However, a comprehensive mechanism of action is still lacking. Here, we investigated how a single dose of the short-acting 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) acts on gene expression from microdissected...

DOI: 10.1038/s41380-024-02655-w (opens in new tab) Full text (opens in new tab) Psychopharmacology Anxiety research Natural compounds

Correction: Study Protocol for 'PsilOCD: A Pharmacological Challenge Study Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity'.

Cureus 2025 Sorcha O'Connor, Kate Godfrey, Sara Reed et al. correction

Background: Obsessive-compulsive disorder (OCD) is a complex condition marked by persistent distressing thoughts and repetitive behaviours. Despite its prevalence, the mechanisms behind OCD remain elusive, and current treatments are limited. This protocol outlines an investigative study for individuals with OCD, exploring the potential of psilocybin to improve key components of cognition...

DOI: 10.7759/cureus.c209 (opens in new tab) Full text (opens in new tab) Psychedelics Mental health Clinical research OCD

Neurogenic Potential of Acacia oerfota: Evaluating the Effects of DMT-Rich Extract on PC12 Cells

Thrita December 31, 2024 Narges Ghasemi Lakeh, Mona Farhadi, Fatemeh Siadat

Background: Acacia species, including Acacia oerfota, are rich in bioactive compounds such as N,N-dimethyltryptamine (DMT), known for its psychoactive properties. Recent studies suggest that low concentrations of DMT may promote neurogenesis and brain plasticity, offering therapeutic potential for neurodegenerative diseases like Alzheimer’s and depression. Methods: A hydroalcoholic extract of...

Exploring the neurobiological correlates of psilocybin-assisted psychotherapy in eating disorders: a review of potential methodologies and implications for the psychedelic study design

Journal of Eating Disorders December 27, 2024 Elena Koning, Cristiano Chaves, Elisa Brietzke et al. 2 citations

Eating disorders (EDs) are a group of debilitating mental illnesses characterized by maladaptive eating behaviors and severe cognitive-emotional dysfunction, directly affecting 1-3% of the population. Standard treatments are not effective in approximately one third of ED cases, representing the need for scientific advancement. There is emerging evidence for the safety and efficacy of...